TLR4 and viral infectious disease: The small-molecule synthetic TLR-4 antagonist, FP7, protected mice from influenza virus-induced lethality and reduced both proinflammatory cytokine gene expression in the lungs and ALI [49] suggesting viral infection also through activating TLR-4 signaling.